Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2022-09-15 Board/Management Inform…
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing changes in the company's commercial organization and management team. It discusses appointments of new Chief Commercial Officers and changes in reporting structure, focusing on management and organizational updates. There is no financial data, earnings information, or detailed financial report content. The document does not present an annual or quarterly report, audit, or earnings release. It is clearly an announcement about management changes, which fits the category of Board/Management Information (MANG). The document length is 7230 characters, which is sufficient for a detailed announcement but does not contain financial statements or analysis. Therefore, the appropriate classification is MANG with high confidence.
2022-09-15 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus and offering information for redeemable income notes (billets à revenu rachetables) issued by Banque de Montréal (BMO). It includes detailed terms of the notes, coupon payments, redemption features, risk factors, hypothetical scenarios, and other investment details. The document is not a financial report like an annual or interim report, nor is it a regulatory filing or announcement. It is a detailed offering document related to a capital raising instrument (redeemable notes) describing the terms and conditions of the securities offered to investors. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2022-09-06 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release providing an update on reimbursement status for the TULSA-PRO medical device, including details about CPT code applications, CMS reimbursement rules, and anticipated future submissions. It does not contain financial statements, management discussion of financial results, or detailed financial data. It is a regulatory announcement related to reimbursement and procedural coding updates rather than a financial report or earnings release. The document length is about 5940 characters, which is relatively short and consistent with a regulatory or capital markets announcement. There is no indication of it being an earnings release, annual or interim report, or other financial filing. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2022-09-02 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-08-04 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-08-04 English
Interim MD&A - English.pdf
Regulatory Filings
2022-08-04 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.